NCT00392002已完成4 期
A Cluster-Randomized Study to Examine National Characteristics and Outcome Measures of GERD Patients Utilizing the PPI Acid Suppression Symptom (PASS) Test for Response [EncomPASS].
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 2,000
- 试验地点
- 2
- 主要终点
- To compare the improvement in burden of overall GERD symptoms after 4 weeks of treatment with Esomeprazole verses maintenance of current therapy in subjects with persistent GERD symptoms.
研究概览
简要总结
To characterize the burden of disease in GERD patients of prescription therapy'
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Signed informed consent, 18 years or older, diagnosis of GERD
排除标准
- •Peptic ulcer disease, upper gastrointestinal surgery, malignancy
结局指标
主要结局
To compare the improvement in burden of overall GERD symptoms after 4 weeks of treatment with Esomeprazole verses maintenance of current therapy in subjects with persistent GERD symptoms.
次要结局
- To examine the relationship of the severity and frequency of GERD symptoms to treatment, at national, and regional levels.
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Impact of GERD on Daily Life (NIS)GERDNCT00545883AstraZeneca2,001
已完成
不适用
Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQGastroesophageal Reflux DiseaseNCT00914342AstraZeneca889
已完成
不适用
LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS)GERDNCT00567619AstraZeneca900
进行中（未招募）
不适用
Preserving the Pre-cardial Fat Pad During Sleeve Gastrectomy on Postoperative Gastroesophageal RefluxSleeve GastrectomyPre-cardial Fat PadExcessive Weight LossTotal Weight LossGastroesophageal Reflux DiseaseNCT06732661Beijing Chao Yang Hospital50
已完成
不适用
Prevalence of Gastroesophageal Reflux Disease in Primary Care Patients With Upper Gastrointestinal SymptomsGastroesophageal Reflux DiseaseNCT01020890AstraZeneca2,210